What's in Generex Biotechnology Corp.'s pipeline?

Generex Biotechnology Corp. has 2 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Generex Biotechnology Corp.'s portfolio?

Top competitors by shared drug class: Mylan Inc., National Institute of Neurosciences and Hospital, Dhaka, University of Campania Luigi Vanvitelli.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/generex-biotechnology-corp.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Generex Biotechnology Corp. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Generex Biotechnology Corp. pipeline: 0 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Generex Oral-lyn™	Generex Oral-lyn™	phase 3	Insulin (oral formulation)	Insulin receptor	Diabetes

Therapeutic area mix

Diabetes · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Mylan Inc. · 1 shared drug class
National Institute of Neurosciences and Hospital, Dhaka · 1 shared drug class
University of Campania Luigi Vanvitelli · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Generex Biotechnology Corp.:

Cite this brief

Drug Landscape (2026). Generex Biotechnology Corp. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/generex-biotechnology-corp. Accessed 2026-05-17.